Benchmark Reiterates Buy Rating on Cineverse (CNVS) Ahead of Q4 Results

Benchmark analyst Daniel L. Kurnos reiterated a Buy rating and $12.00 price target on Cineverse (NASDAQ: CNVS).

The analyst commented, "Cineverse (CNVS: Buy, PT $12) is set to report F4Q26 (March) earnings on Friday before the market opens. We believe this quarter will exemplify why the IndiCue and Giant acquisitions were both game-changing and necessary, as revenue begins to ramp and EBITDA turns from negative to positive. While it is probably too early in the year for management to raise previously issued FY27 guidance of $110-120 million in revenue and $10-20 million in EBITDA, we should at least get a taste for the top line improvement, with the bottom line to follow in F1Q27. Furthermore, investors should finally be able to officially cheer the dilution of the impact of the movie business ex-Terrifier on results as it becomes a much more immaterial portion of the total. And, with political on the horizon plus overall strength in the CTV and audio markets, the chance for upside from the businesses that matter near-term is real as we wait for deal synergies and additional business wins to materialize."

For an analyst ratings summary and ratings history on Cineverse click here. For more ratings news on Cineverse click here.

Shares of Cineverse closed at $2.85 yesterday.

You May Also Be Interested In

• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy